Stay updated with breaking news from Phenotypic Screening. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MIT researchers built DiffDock, a diffusion generative model that could potentially find new drugs faster than traditional methods and reduce the potential for adverse side effects.
In this interview, we speak to Ceri Wiggins, a Director at AstraZeneca, about the many applications of CRISPR and its role in discovering new COPD therapies.
/PRNewswire/ -- ThinkCyte and Axcelead Drug Discovery Partners (DDP) today announced a research partnership focused on developing new approaches to screen...
Largest reported organ-on-a-chip screen ever performed on a 3D angiogenesis assayLEIDEN, the Netherlands, May 27, 2021 / B3C newswire / -- MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center. The center facilitates large-scale screening campaigns on...